EFFECT OF INTRAVENOUS LEVOSIMENDAN, A CALCIUM SENSITIZER, ON THE SURVIVAL OF HOSPITALIZED PATIENTS WITH HEART FAILURE ArticlePacker M., Nieminen M.S., Hasenfuss G., Follath F., Cleland J.GF., Moiseyev V.S., Lechat P., Pajunen P., Akkila J.Circulation. Vol. 100. 1999. P.. 646-646
HDL PHOSPHOLIPID: A NATURAL INHIBITOR OF ALZHEIMER'S AMYLOID BETA-FIBRILLOGENESIS? ArticleKoudinov A.R., Koudinova N.V., Berezov T.T., Ivanov Y.D.Clinical Chemistry and Laboratory Medicine. Vol. 37. 1999. P.. 993-994